[Molecular cancer therapy using tyrosine kinase inhibitors].
Lacotte-Thierry
Laurence
L
Service d'oncologie hématologique et de thérapie cellulaire Hôpital de la Milétrie BP 577 86021 Poitiers.
Guilhot
François
F
D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000201:enzymology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015398:Signal Transduction; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000201:enzymology
D004791:Enzyme Inhibitors; D011505:Protein-Tyrosine Kinases
Traitement moléculaire des cancers par l'inhibition des tyrosine-kinases.